Literature DB >> 12185221

Management of colorectal cancer.

A Leslie1, R J C Steele.   

Abstract

Colorectal cancer is the second most common cause of cancer death in the UK. Prompt investigation of suspicious symptoms is important, but there is increasing evidence that screening for the disease can produce significant reductions in mortality. High quality surgery is of paramount importance in achieving good outcomes, particularly in rectal cancer, but adjuvant radiotherapy and chemotherapy have important parts to play. The treatment of advanced disease is still essentially palliative, although surgery for limited hepatic metastases may be curative in a small proportion of patients.

Entities:  

Mesh:

Year:  2002        PMID: 12185221      PMCID: PMC1742469          DOI: 10.1136/pmj.78.922.473

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  48 in total

Review 1.  Colorectal cancer update. Prevention, screening, treatment, and surveillance for high-risk groups.

Authors:  J H Bond
Journal:  Med Clin North Am       Date:  2000-09       Impact factor: 5.456

2.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Antimicrobial prophylaxis in colorectal surgery.

Authors:  A M Glenny; F Song
Journal:  Qual Health Care       Date:  1999-06

4.  Bowel preparation with oral polyethylene glycol electrolyte solution vs. no preparation in elective open colorectal surgery: prospective, randomized study.

Authors:  R P Miettinen; S T Laitinen; J T Mäkelä; M E Pääkkönen
Journal:  Dis Colon Rectum       Date:  2000-05       Impact factor: 4.585

5.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

6.  Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

Authors:  P M Hoff; R Ansari; G Batist; J Cox; W Kocha; M Kuperminc; J Maroun; D Walde; C Weaver; E Harrison; H U Burger; B Osterwalder; A O Wong; R Wong
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

7.  Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

Authors:  J Y Douillard; D Cunningham; A D Roth; M Navarro; R D James; P Karasek; P Jandik; T Iveson; J Carmichael; M Alakl; G Gruia; L Awad; P Rougier
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

8.  Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers.

Authors:  K B Michels; K J Joshipura; B A Rosner; M J Stampfer; C S Fuchs; G A Colditz; F E Speizer; W C Willett
Journal:  J Natl Cancer Inst       Date:  2000-11-01       Impact factor: 13.506

9.  Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery.

Authors:  R G Beets-Tan; G L Beets; R F Vliegen; A G Kessels; H Van Boven; A De Bruine; M F von Meyenfeldt; C G Baeten; J M van Engelshoven
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

10.  Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

Authors:  L B Saltz; J V Cox; C Blanke; L S Rosen; L Fehrenbacher; M J Moore; J A Maroun; S P Ackland; P K Locker; N Pirotta; G L Elfring; L L Miller
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

View more
  4 in total

1.  Angiography for diagnosis and treatment of colorectal cancer.

Authors:  Jin Gu; Zhao-Lai Ma; Ying Li; Ming Li; Guang-Wei Xu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

2.  Application of a non-parametric non-mixture cure rate model for analyzing the survival of patients with colorectal cancer in Iran.

Authors:  Mehdi Azizmohammad Looha; Mohamad Amin Pourhoseingholi; Maryam Nasserinejad; Hadis Najafimehr; Mohammad Reza Zali
Journal:  Epidemiol Health       Date:  2018-09-17

3.  Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.

Authors:  Arseniy E Yuzhalin; Su Yin Lim; Alex N Gordon-Weeks; Roman Fischer; Benedikt M Kessler; Dihua Yu; Ruth J Muschel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

4.  Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.

Authors:  Gong-Peng Dai; Li-Ping Wang; Yu-Qing Wen; Xue-Qun Ren; Shu-Guang Zuo
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.